Commonwealth of Pennsylvania Public School Empls Retrmt SYS lifted its holdings in shares of National Health Investors, Inc. (NYSE:NHI – Free Report) by 4.9% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 14,823 shares of the real estate investment trust’s stock after buying an additional 696 shares during the quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS’s holdings in National Health Investors were worth $1,039,000 at the end of the most recent quarter.
A number of other hedge funds have also bought and sold shares of NHI. Private Advisor Group LLC raised its holdings in National Health Investors by 159.5% during the 1st quarter. Private Advisor Group LLC now owns 15,206 shares of the real estate investment trust’s stock valued at $1,123,000 after acquiring an additional 9,346 shares during the period. Allianz Asset Management GmbH raised its stake in shares of National Health Investors by 104.0% during the 1st quarter. Allianz Asset Management GmbH now owns 56,928 shares of the real estate investment trust’s stock valued at $4,205,000 after purchasing an additional 29,016 shares during the period. Universal Beteiligungs und Servicegesellschaft mbH purchased a new stake in National Health Investors during the 1st quarter worth about $645,000. Zurcher Kantonalbank Zurich Cantonalbank lifted its holdings in National Health Investors by 2.1% during the 1st quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 23,810 shares of the real estate investment trust’s stock worth $1,759,000 after purchasing an additional 489 shares in the last quarter. Finally, LPL Financial LLC boosted its stake in National Health Investors by 6.2% in the 1st quarter. LPL Financial LLC now owns 24,248 shares of the real estate investment trust’s stock worth $1,791,000 after purchasing an additional 1,406 shares during the period. 62.51% of the stock is currently owned by hedge funds and other institutional investors.
Wall Street Analyst Weigh In
NHI has been the topic of several analyst reports. Weiss Ratings reiterated a “buy (b-)” rating on shares of National Health Investors in a research report on Wednesday, October 8th. Cantor Fitzgerald initiated coverage on shares of National Health Investors in a research note on Wednesday, October 1st. They issued an “overweight” rating and a $90.00 target price on the stock. National Bankshares set a $90.00 price target on shares of National Health Investors in a report on Wednesday, October 1st. Wells Fargo & Company upped their price target on shares of National Health Investors from $76.00 to $80.00 and gave the stock an “equal weight” rating in a report on Wednesday, August 27th. Finally, Truist Financial increased their price objective on National Health Investors from $77.00 to $81.00 and gave the stock a “buy” rating in a research report on Friday, August 15th. One analyst has rated the stock with a Strong Buy rating, four have given a Buy rating and one has assigned a Hold rating to the company’s stock. According to MarketBeat, National Health Investors has an average rating of “Buy” and a consensus price target of $84.83.
National Health Investors Price Performance
Shares of NYSE:NHI opened at $78.91 on Monday. The company’s fifty day moving average price is $76.66 and its 200-day moving average price is $74.49. The company has a debt-to-equity ratio of 0.75, a current ratio of 10.91 and a quick ratio of 10.91. The firm has a market capitalization of $3.76 billion, a price-to-earnings ratio of 25.21, a PEG ratio of 3.31 and a beta of 0.74. National Health Investors, Inc. has a one year low of $65.13 and a one year high of $80.56.
National Health Investors (NYSE:NHI – Get Free Report) last posted its quarterly earnings data on Thursday, November 6th. The real estate investment trust reported $1.32 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.24 by $0.08. The company had revenue of $83.36 million during the quarter, compared to the consensus estimate of $85.66 million. National Health Investors had a net margin of 40.97% and a return on equity of 10.32%. The firm’s revenue was down 1.8% compared to the same quarter last year. During the same period in the previous year, the firm posted $1.03 EPS. National Health Investors has set its FY 2025 guidance at 4.880-4.91 EPS. On average, equities research analysts anticipate that National Health Investors, Inc. will post 4.41 earnings per share for the current fiscal year.
National Health Investors Announces Dividend
The company also recently disclosed a quarterly dividend, which will be paid on Friday, January 30th. Stockholders of record on Wednesday, December 31st will be given a dividend of $0.92 per share. The ex-dividend date is Wednesday, December 31st. This represents a $3.68 annualized dividend and a dividend yield of 4.7%. National Health Investors’s dividend payout ratio is 116.09%.
National Health Investors Profile
Incorporated in 1991, National Health Investors, Inc (NYSE:NHI) is a real estate investment trust specializing in sale, leasebacks, joint-ventures, senior housing operating partnerships, and mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent living, assisted living and memory care communities, entrance-fee retirement communities, skilled nursing facilities, and specialty hospitals.
Further Reading
- Five stocks we like better than National Health Investors
- Top Biotech Stocks: Exploring Innovation Opportunities
- DoorDash’s Recent Stock Dip Equals 60% Upside
- What is the FTSE 100 index?
- Wall Street Loves Williams-Sonoma Right Now—Here’s Why the Stock Could Soar in 2026
- Energy and Oil Stocks Explained
- Meta Wins FTC Fight, Keeps Instagram Growth Machine Intact
Receive News & Ratings for National Health Investors Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for National Health Investors and related companies with MarketBeat.com's FREE daily email newsletter.
